Search

Your search keyword '"Nilubol D"' showing total 51 results

Search Constraints

Start Over You searched for: Author "Nilubol D" Remove constraint Author: "Nilubol D" Database MEDLINE Remove constraint Database: MEDLINE
51 results on '"Nilubol D"'

Search Results

1. Characterization of the immunodominant regions of Senecavirus A-VP1 structural protein via ELISA epitope mapping.

2. The Comparative Full-Length Genome Characterization of African Swine Fever Virus Detected in Thailand.

3. The development of a lateral flow immunochromatographic test strip for measurement of specific IgA and IgG antibodies level against porcine epidemic diarrhea virus in pig milk.

4. A Standardized Pipeline for Assembly and Annotation of African Swine Fever Virus Genome.

5. Comprehensive Characterization of the Genetic Landscape of African Swine Fever Virus: Insights into Infection Dynamics, Immunomodulation, Virulence and Genes with Unknown Function.

6. Effect of a Multi-Species Direct-Fed Microbial on Growth Performance, Nutrient Digestibility, Intestinal Morphology and Colonic Volatile Fatty Acids in Weanling Pigs.

7. Evolution and virulence of porcine epidemic diarrhea virus following in vitro and in vivo propagation.

9. Intradermal needle-free injection prevents African Swine Fever transmission, while intramuscular needle injection does not.

10. Co-infection of porcine deltacoronavirus and porcine epidemic diarrhea virus induces early TRAF6-mediated NF-κB and IRF7 signaling pathways through TLRs.

11. Using a concurrent challenge with porcine circovirus 2 and porcine reproductive and respiratory syndrome virus to compare swine vaccination programs.

12. The phylodynamics of emerging porcine deltacoronavirus in Southeast Asia.

13. Enhancing epitope of PEDV spike protein.

14. Intranasal delivery of inactivated PRRSV loaded cationic nanoparticles coupled with enterotoxin subunit B induces PRRSV-specific immune responses in pigs.

15. Safety of PRRSV-2 MLV vaccines administrated via the intramuscular or intradermal route and evaluation of PRRSV transmission upon needle-free and needle delivery.

16. Development and validation of indirect ELISA for antibody detection against different protein antigens of porcine epidemic diarrhea virus in the colostrum and milk of sows.

17. Coinfection of porcine deltacoronavirus and porcine epidemic diarrhea virus increases disease severity, cell trophism and earlier upregulation of IFN-α and IL12.

18. Field trials evaluating the efficacy of porcine epidemic diarrhea vaccine, RNA (Harrisvaccine) in the Philippines.

19. Cationic Polylactic Acid-Based Nanoparticles Improve BSA-FITC Transport Across M Cells and Engulfment by Porcine Alveolar Macrophages.

20. Immune response and protective efficacy of intramuscular and intradermal vaccination with porcine reproductive and respiratory syndrome virus 1 (PRRSV-1) modified live vaccine against highly pathogenic PRRSV-2 (HP-PRRSV-2) challenge, either alone or in combination with of PRRSV-1.

21. Cell-mediated immune response and protective efficacy of porcine reproductive and respiratory syndrome virus modified-live vaccines against co-challenge with PRRSV-1 and PRRSV-2.

22. Retrospective study, full-length genome characterization and evaluation of viral infectivity and pathogenicity of chimeric porcine deltacoronavirus detected in Vietnam.

23. The full-length genome characterization, genetic diversity and evolutionary analyses of Senecavirus A isolated in Thailand in 2016.

24. Protective Effects of Cell-Free Supernatant and Live Lactic Acid Bacteria Isolated from Thai Pigs Against a Pandemic Strain of Porcine Epidemic Diarrhea Virus.

25. The first detection of Senecavirus A in pigs in Thailand, 2016.

26. Rapid Transient Production of a Monoclonal Antibody Neutralizing the Porcine Epidemic Diarrhea Virus (PEDV) in Nicotiana benthamiana and Lactuca sativa.

27. A new cell-to-cell interaction model for epithelial microfold cell formation and the enhancing effect of epidermal growth factor.

28. Immune response of gilts to single and double infection with porcine epidemic diarrhea virus.

29. Retrospective investigation and evolutionary analysis of a novel porcine deltacoronavirus strain detected in Thailand from 2008 to 2015.

30. Evolutionary and epidemiological analyses based on spike genes of porcine epidemic diarrhea virus circulating in Thailand in 2008-2015.

31. The genetic diversity and complete genome analysis of two novel porcine deltacoronavirus isolates in Thailand in 2015.

32. Different Lineage of Porcine Deltacoronavirus in Thailand, Vietnam and Lao PDR in 2015.

33. Humoral immune responses and viral shedding following vaccination with modified live porcine reproductive and respiratory syndrome virus vaccines.

34. The first detection and full-length genome sequence of porcine deltacoronavirus isolated in Lao PDR.

35. Full-length genome analysis of two genetically distinct variants of porcine epidemic diarrhea virus in Thailand.

36. Complete Genome Sequence of Porcine Deltacoronavirus Isolated in Thailand in 2015.

37. Complete genome characterization of porcine epidemic diarrhea virus in Vietnam.

38. Complete Genome Sequences of Two Genetically Distinct Variants of Porcine Epidemic Diarrhea Virus in the Eastern Region of Thailand.

39. Dynamics and evolution of highly pathogenic porcine reproductive and respiratory syndrome virus following its introduction into a herd concurrently infected with both types 1 and 2.

40. Complete genome sequence of porcine epidemic diarrhea virus in Vietnam.

41. Genetic diversity of ORF3 and spike genes of porcine epidemic diarrhea virus in Thailand.

42. Dynamics and evolution of porcine reproductive and respiratory syndrome virus (PRRSV) ORF5 following modified live PRRSV vaccination in a PRRSV-infected herd.

43. Genetic diversity of the ORF5 gene of porcine reproductive and respiratory syndrome virus (PRRSV) genotypes I and II in Thailand.

44. Porcine reproductive and respiratory syndrome virus, Thailand, 2010-2011.

45. Vaccine efficacy and immune response to swine influenza virus challenge in pigs infected with porcine reproductive and respiratory syndrome virus at the time of SIV vaccination.

46. Melamine- and cyanuric acid-associated renal failure in pigs in Thailand.

47. Pharmacokinetics of ceftiofur hydrochloride in pigs infected with porcine reproductive and respiratory syndrome virus.

48. Porcine circovirus type 2 (PCV2) distribution and replication in tissues and immune cells in early infected pigs.

49. The immune response and maternal antibody interference to a heterologous H1N1 swine influenza virus infection following vaccination.

50. Effectiveness of transdermal, needle-free injections for reducing pork carcass defects.

Catalog

Books, media, physical & digital resources